Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-02-11

Clinical Trial Update: A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic/pharmacodynamic study comparing fluticasone propionate and salmeterol delivered by ROTAHALER versus DISKUS in patients with moderate ast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)
  • Salmeterol (salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: WITHDRAWN